Insights into the regulation of NAD(+) levels and Sirtuin1 activity: miR-506 suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 25/April/2014, 5.43 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the regulation of NAD(+) levels and Sirtuin1 activity: miR-506 suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 25/April/2014, 5.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Insights into the regulation of NAD(+) levels and Sirtuin1 activity: δ-tocotrienol (Vitamin-E) suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 25/April/2014, 5.40 am
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into the regulation of NAD(+) levels and Sirtuin1 activity: δ-tocotrienol (Vitamin-E) suppresses the expression of NAMPT, the rate-limiting enzyme for NAD(+) biosynthesis, via up regulation of its target gene, 25/April/2014, 5.40 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
Insights into Enhancing the chemosensitivity of metastatic breast cancers: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, sensitizes drug-resistant breast cancer cells by targeting Bcl-XL through its target gene, 24/April/2014, 14.11
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into Enhancing the chemosensitivity of Metastastic breast cancers: Fulvestrant/Faslodex, a Selective estrogen receptor down-regulator, sensitizes drug-resistant breast cancer cells by targeting Bcl-XK through its target gene, 24/April/2014, 14.11, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org
A link between the regulation of Cell-density-dependent miRNA Biogenesis and tumor suppression: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, promotes widespread miRNA biogenesis via up regulation of its target gene, 24/April/2014, 13.53
Profs. Drs. R I Gregory, Camargo FD and their co-workers from Boston Children’s Hospital, MA, USA; Department of Biological Chemistry and Molecular Pharmacology and Department of Pediatrics, Harvard Medical School, Boston, MA, USA; and Harvard Stem Cell Institute, Boston, MA, USA had reported in the prestigious journal Cell (Feb 27, 2014) that “Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer” On the foundation of […]
Insights into Enhancing the chemosensitivity of metastatic breast cancers: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, sensitizes drug-resistant breast cancer cells by targeting Multidrug Resistance-Associated Protein 2 (MRP2)/ABCC2 through its target gene, 24/April/2014, 13.42
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into Enhancing the chemosensitivity of metastatic breast cancers: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, sensitizes drug-resistant breast cancer cells by targeting Multidrug Resistance-Associated Protein 2 (MRP2)/ABCC2 through its target gene, 24/April/2014, 13.42, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line […]
Insights into Enhancing the chemosensitivity of tumors: miRNA-545 sensitizes drug-resistant cancer cells by targeting Bcl-XL through its target gene, 24/April/2014, 13.30
Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Insights into Enhancing the chemosensitivity of tumors: miRNA-545 sensitizes drug-resistant cancer cells by targeting Bcl-XL through its target gene, 24/April/2014, 13.30, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org Courtesy: When you cite drop us a line at info@genomediscovery.org